Cited by 380Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementVenous Thromboembolism Diagnosis and Management

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events

Open access

BOTTO, GIOVANNI L., PADELETTI, LUIGI, SANTINI, MASSIMO, CAPUCCI, ALESSANDRO, GULIZIA, MICHELE, ZOLEZZI, FRANCESCO, FAVALE, STEFANO, MOLON, GIULIO, RICCI, RENATO, BIFFI, MAURO, RUSSO, GIOVANNI, VIMERCATI, MARCO, CORBUCCI, GIORGIO, BORIANI, GIUSEPPE·2009·Journal of Cardiovascular Electrophysiology

DOI 10.1111/j.1540-8167.2008.01320.x

Open this paper in CoChat — free account

Abstract

INTRODUCTION: Asymptomatic atrial fibrillation (AF) can expose patients to the risk of stroke. The primary objective of this study was to assess the incidence of thromboembolic events in relationship with CHADS(2) (congestive heart failure, hypertension, age >or=75 years, diabetes mellitus, and prior stroke, or transient ischemic attack) score and AF presence/duration. The secondary objective was to compare intermittent versus continuous monitoring strategies. METHODS AND RESULTS: Data from patients with an implanted pacemaker and a history of AF were analyzed. Thromboembolic risk was quantified through CHADS(2) score. Three AF groups were considered: patients with <5-minutes AF on 1 day (AF-free); patients with >5-minutes AF on 1 day but <24 hours (AF-5 minutes); patients with AF episodes >24 hours (AF-24 hours). Monitoring strategies involving 24-hour Holter, 1-week Holter, and 30-day Holter were simulated. Data from 568 patients continuously monitored for 1 year were analyzed: 171 (30%) had CHADS(2) score = 0; 269 (47%) had CHADS(2) score = 1; 111 (20%) had CHADS(2) score = 2; and 17 (3%) had CHADS(2) score >or= 3. During follow-up, 14 patients (2.5%) had an ischemic thromboembolic event. AF-24 hours patients numbered 223 (39.2%); AF-5 minutes, 179 (31.5%); and AF-free, 29.2%. By combining AF presence/duration with CHADS(2) score, two subpopulations with markedly different risks of events (0.8% vs 5%, P = 0.035) were identified, the former corresponding to AF-free with CHADS(2) 5 minutes was 44.4%, 50.4%, and 65.1% for 24-hour Holter, 1-week Holter, and 1-month Holter monitoring, respectively. CONCLUSION: In patients with recurrent AF episodes, risk stratification for thromboembolic events can be improved by combining CHADS(2) score with AF presence/duration.

Integrity signals

Registry

Crossref · 10.1111/j.1540-8167.2008.01320.x

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION
Petersen, P., GODTFREDSEN, J., Boysen, G., Andersen, E. D., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,814
Stroke Prevention in Atrial Fibrillation Study. Final results.
Prevention, S., & Atrial Fibrillation Investigators (1991) · Circulation · doi:10.1161/01.cir.84.2.527 · Cited by 1,696
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators* (1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232201 · Cited by 1,525
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article
Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., Silka, M. J., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02528-7 · Cited by 1,273
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Ezekowitz, M. D., Bridgers, S. L., James, K. E., Carliner, N. H., Colling, C. L., Gornick, C. C., Krause-Steinrauf, H. J., Kurtzke, J. F., Nazarian, S. M., Radford, M. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272002 · Cited by 1,204
Canadian atrial fibrillation anticoaguiation (CAFA) study
Connolly, S. J., Laupacis, A., Gent, M., Roberts, R. S., Cairns, J. A., & Joyner, C. D. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90585-w · Cited by 1,109
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Barnes, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280227 · Cited by 1,072
PSYCHOSOMATIC MEDICINE
Lipowski, Z. J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92478-7 · Cited by 951
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article
Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., Silka, M. J., et al. (2002) · Circulation · doi:10.1161/01.cir.0000035996.46455.09 · Cited by 907
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)
Glotzer, T. V., Hellkamp, A. S., Zimmerman, J., Sweeney, M. O., Yee, R., Marinchak, R., Cook, J., Paraschos, A., Love, J., Radoslovich, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000057981.70380.45 · Cited by 750
Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device
Israel, C. W., Grönefeld, G., Ehrlich, J. R., Li, Y., & Hohnloser, S. H. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.027 · Cited by 478
Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy
Hohnloser, S. H., Pajitnev, D., Pogue, J. M., Healey, J. S., Pfeffer, M. A., Yusuf, S., & Connolly, S. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.076 · Cited by 459
Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia Pacemakers
Capucci, A., Santini, M., Padeletti, L., Gulizia, M. M., Botto, G., Boriani, G., Ricci, R. P., Favale, S., Zolezzi, F., Belardino, N. D., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.044 · Cited by 400
Self-citation
Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
Flaker, G. C., Belew, K., Beckman, K., Vidaillet, H., Kron, J., Safford, R., Mickel, M., & Barrell, P. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.06.032 · Cited by 341
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial
FETSCH, T. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.04.015 · Cited by 334
Comparison of continuous versus intermittent monitoring of atrial arrhythmias
Ziegler, P., Koehler, J. L., & Mehra, R. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.07.030 · Cited by 281
For the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators : Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
Ezekowitz (1992) · New England Journal of Medicine · Cited by 266
The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency
Lee, M. A., Weachter, R., Pollak, S. J., Kremers, M. S., Naik, A. M., Silverman, R., Tuzi, J., Wang, W., Johnson, L. J., & Euler, D. E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00426-1 · Cited by 200
Cerebral Diffusion‐Weighted Magnetic Resonance Imaging: A Tool to Monitor the Thrombogenicity of Left Atrial Catheter Ablation
Lickfett, L., HACKENBROCH, M., Lewalter, T., Selbach, S. G. M., SCHWAB, J. O., Yang, A., Balta, O., SCHRICKEL, J. W., BITZEN, A., Lüderitz, B., et al. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.00279.x · Cited by 200
Critical Analysis of Dual-Chamber Implantable Cardioverter-Defibrillator Arrhythmia Detection
Wilkoff, B. L., Kühlkamp, V., VOLOSIN, K. J., Ellenbogen, K. A., Waldecker, B., Kacet, S., Gillberg, J. M., & DeSouza, C. (2001) · Circulation · doi:10.1161/01.cir.103.3.381 · Cited by 170
Detection of Atrial Fibrillation and Flutter by a Dual-Chamber Implantable Cardioverter-Defibrillator
Swerdlow, C. D., Schšls, W., Dijkman, B., Jung, W., Sheth, N. V., Olson, W. H., Gunderson, B. D., & for the Worldwide Jewel AF Investigators (2000) · Circulation · doi:10.1161/01.cir.101.8.878 · Cited by 168
Newly Detected Atrial Fibrillation and Compliance With Antithrombotic Guidelines
Glazer, N. L. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.3.246 · Cited by 167
Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care
DeWilde, S., Carey, I. M., Emmas, C., Richards, N., & Cook, D. G. (2005) · Heart · doi:10.1136/hrt.2005.069492 · Cited by 167
Suppression of paroxysmal atrial tachyarrhythmias—results of the SOPAT trial
PATTEN, M., MAAS, R., BAUER, P., LUDERITZ, B., SONNTAG, F., DLUZNIEWSKI, M., HATALA, R., OPOLSKI, G., MULLER, H., & MEINERTZ, T. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.014 · Cited by 157
Pace‐Termination and Pacing for Prevention of Atrial Tachyarrhythmias: Results from a Multicenter Study with an Implantable Device for Atrial Therapy
Israel, C. W., Hügl, B. J., Unterberg‐Buchwald, C., Lawo, T., Kennis, I., Hettrick, D. A., & Hohnloser, S. H. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.01121.x · Cited by 155
Antithrombotic treatment in atrial fibrillation
Lip, G. Y. H., & Boos, C. J. (2005) · Postgraduate Medical Journal · doi:10.1136/hrt.2005.066944 · Cited by 124
Event‐Recorder Monitoring in the Diagnosis of Atrial Fibrillation in Symptomatic Patients: Subanalysis of the SOPAT Trial
Patten, M., Maas, R., Karim, A., MÜLLER, H., SIMONOVSKY, R., & Meinertz, T. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00609.x · Cited by 95
Trends in Anticoagulation for Atrial Fibrillation in the U.S.
Rowan, S. B., Bailey, D. N., Bublitz, C. E., & Anderson, R. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.045 · Cited by 72
Antithrombotic treatment in atrial fibrillation
Kalra, L., & Lip, G. Y. H. (2006) · Heart · doi:10.1136/hrt.2006.099911 · Cited by 42
Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: The TRENDS study
Glotzer, T. V., Daoud, E. G., Wyse, D. G., Singer, D. E., Holbrook, R., Pruett, K., Smith, K., & Hilker, C. E. (2006) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-006-7622-y · Cited by 40
Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence A prospective, multicentre study
Bellocci, F. (1999) · EP Europace · doi:10.1053/eupc.1999.0049 · Cited by 34
The impact of asymptomatic atrial fibrillation**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
Kaufman, E. S., & Waldo, A. L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.013 · Cited by 27
Asymptomatic Atrial Fibrillation on Device Interrogation
Lim, H. S., & Lip, G. Y. H. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01194.x · Cited by 26
Limited Clinical Utility of Holter Monitoring in Patients with Palpitations or Altered Consciousness: Analysis of 8973 Recordings in 7394 Patients
Sulfi, S., Balami, D., Sekhri, N., Suliman, A., Kapur, A., Archbold, A., Ranjadayalan, K., & Timmis, A. (2008) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2007.00199.x · Cited by 25
Atrial Tachyarrhythmia Recurrence Temporal Patterns in Bradycardia Patients Implanted with Antitachycardia Pacemakers
Ricci, R. P., Santini, M., Padeletti, L., Boriani, G., Capucci, A., Botto, G., Gulizia, M. M., Inama, G., Galati, A., Solimene, F., et al. (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03317.x · Cited by 25
Self-citation
Rate control in patients with pacemaker affected by brady-tachy form of sick sinus syndrome
Boriani, G., Padeletti, L., Santini, M., Gulizia, M. M., Orazi, S., Botto, G., Capucci, A., Biffi, M., Martignani, C., Ricci, R. P., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.04.001 · Cited by 9
Self-citation

Flagged first, then by citations

Research works printed but not linked: 5

10.1046/j.1540-8167.2001.01121.x · DOI
10.1161/01.CIR.101.8.878 · DOI
10.1111/j.1540-8167.2006.00609.x · DOI
10.1136/hrt.2006.099911 · DOI
10.1111/j.1540-8167.2008.01194.x · DOI

Sorted by citations

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,072
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
Ommen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.044 · Cited by 997
Antithrombotic Therapy for Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R. A., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M. P., Werring, D. J., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.07.040 · Cited by 963
Self-citation
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807

See all 380

Authors: BOTTO, G. L., PADELETTI, L., SANTINI, M., CAPUCCI, A., GULIZIA, M., ZOLEZZI, F., FAVALE, S., MOLON, G., RICCI, R., BIFFI, M., RUSSO, G., VIMERCATI, M., CORBUCCI, G., & BORIANI, G.
Affiliations: Ospedale Sant'Anna (IT)
University of Florence (IT)
Ospedale San Filippo Neri (IT)
Guglielmo da Saliceto Hospital (IT)
Ospedale Garibaldi (IT)
Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT)
Ospedale Sacro Cuore Don Calabria (IT)
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
Medtronic (Italy) (IT)
Corresponding author: BOTTO, GIOVANNI L.
RUSSO, GIOVANNI
ORCID: BOTTO, GIOVANNI L.
GULIZIA, MICHELE
FAVALE, STEFANO
MOLON, GIULIO
RICCI, RENATO
BIFFI, MAURO
BORIANI, GIUSEPPE
Venue: Journal of Cardiovascular Electrophysiology
Publisher: Wiley
Published: 2009-02-20
Volume: 20
Issue: 3
Pages: 241-248
ISSN: 1045-3873 (ISSN-L)
1540-8167
DOI: 10.1111/j.1540-8167.2008.01320.x
OpenAlex: W2075749661
Cited by: 380
References: 40
Citations by year: 2026: 4 · 2025: 3 · 2024: 15 · 2023: 17 · 2022: 16 · 2021: 21 · 2020: 19 · 2019: 19 · 2018: 37 · 2017: 31 · 2016: 30 · 2015: 39 · 2014: 27 · 2013: 30 · 2012: 26
FWCI: 11.16
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: cc-by
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Journal of Cardiovascular Electrophysiology (publishedVersion)
PubMed (publishedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
Florence Research (University of Florence) (submittedVersion)
IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords: atrial fibrillation, thromboembolic risk, CHADS2 score, atrial fibrillation duration, continuous cardiac monitoring, Holter monitoring, intermittent monitoring, stroke risk stratification, implantable pacemaker, asymptomatic atrial fibrillation, anticoagulation, antiplatelet therapy, antiarrhythmic drugs, catheter ablation
MeSH terms: Aged, Atrial Fibrillation, Female, Humans, Italy, Male, Prognosis, Risk Factors, Thromboembolism, Electrocardiography, Ambulatory, Comorbidity, Incidence, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks